Cronos (CRON) EBT Margin (2018 - 2026)

Cronos' (CRON) quarterly EBT Margin came in at 40.12% in Q1 2026, down 3530.0% year-on-year from 1.17% in Q1 2025, and up 244.25% quarter-over-quarter from 27.81% in Q4 2025.

Cronos (CRON) EBT Margin (2018 - 2026) Analysis & Trends

Cronos' EBT Margin history runs 9 years deep, the most recent figure standing at 40.12% for Q1 2026.

  • On a quarterly basis, EBT Margin fell 3530.0% year-over-year to 40.12% in Q1 2026; TTM through Mar 2026 was 4.18%, a 8557.0% decrease from a year earlier, with the FY2025 full-year figure at 11.68%, down 4279.0% from the prior year.
  • EBT Margin improved to 40.12% in Q1 2026 per CRON's latest filing, from 27.81% in the prior quarter.
  • Across five years, EBT Margin topped out at 104.78% in Q4 2022 and bottomed at 1519.35% in Q4 2024.
  • The 5-year median for EBT Margin is 27.81% (2025), against an average of 146.03%.
  • Across the five-year window, EBT Margin slumped 200277 bps in 2022 and surged 149153 bps in 2025, its largest moves.
  • Year by year, EBT Margin stood at 104.78% in 2022, then sank by 282 bps to 190.3% in 2023, then slumped by 698 bps to 1519.35% in 2024, then surged by 98 bps to 27.81% in 2025, then soared by 244 bps to 40.12% in 2026.
  • Per Business Quant, the three latest CRON EBT Margin figures stand at 40.12% (Q1 2026), 27.81% (Q4 2025), and 55.31% (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBT Margin (Qtr)
1 Haleon 87.22 Bn 85.35 Bn - -
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn 10.97%
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn 33.51%
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn -41.57%
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn 40.73%
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn - -
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn -7.05%
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn 30.30%
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn 6.35%
10 Cronos 1.04 Bn 267.78 Mn 19.15 Mn 40.12%

Historic Data

Download Data
DateValue
Mar 31, 2026 40.12%
Dec 31, 2025 -27.81%
Sep 30, 2025 55.31%
Jun 30, 2025 -361.28%
Mar 31, 2025 75.43%
Dec 31, 2024 -1,519.35%
Sep 30, 2024 37.44%
Jun 30, 2024 -28.27%
Mar 31, 2024 -12.03%
Dec 31, 2023 -190.30%
Sep 30, 2023 -11.46%
Jun 30, 2023 -22.65%
Mar 31, 2023 -275.83%
Dec 31, 2022 104.78%
Sep 30, 2022 -151.83%
Jun 30, 2022 -65.82%
Mar 31, 2022 -128.99%
Dec 31, 2021 2,078.54%
Sep 30, 2021 1,850.94%
Jun 30, 2021 -1,144.49%